Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomic and Cellular Inflammaging Investigation Study of Patients With Acute Coronary Syndrome (ACS)

NCT07429227 is registered in ClinicalTrials.gov with Casa di Cura Dott. Pederzoli as lead sponsor.

NCT NCT07429227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07429227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomic and Cellular Inflammaging Investigation Study of Patients With Acute Coronary Syndrome (ACS)
Lead sponsor
Casa di Cura Dott. Pederzoli
Phase
Not applicable
Overall status
Recruiting
Start date
March 31, 2026
Completion date
March 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes (acs)